chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from  a physician and a healthcare worker, refers to a female patient of currently 34 years old. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On unknown dates, the patient was vaccinated with an unspecified number of doses of an unspecified measles vaccine (manufacturer unknown) (strength, dose, route of administration, anatomical location, lot number and expiration date were unknown) for prophylaxis. It was reported that, on an unknown date, a "blood work" was performed to the patient and the results showed  that she had a low measles titer (measles antibody negative). The patient sought medical attention by visiting the physician's office. On 28-MAR-2017, the patient was vaccinated with a dose of M-M-R II (strength, dose, route of administration, lot number and expiration date were unknown) for prophylaxis because of the event. The outcome of measles antibody negative was unknown. The causality between  the unspecified measles vaccine (manufacturer unknown) and the event was not provided. Additional information has been requested.
Case number PHEH2015US002938, is an initial spontaneous report received from a nurse on 06 FEB 2015. This report refers to a 27 year old female patient. Medical history and concomitant medication was not reported. On 14 JAN 2015, she received FLUVIRIN 2014/2015 (batch number: 146525) 0.5 ml intramuscular that reached 48 degree Fahrenheit for 9 hours. Event outcome, seriousness and causality assessment was not reported. No further information was provided.
Red, erythematous papulovesicular rash. 1.5 x 1.5 inches, x 1 spot at site of vaccination. Tender to touch. No D/C. No drainage.
Little sinus pressure; may be a little bit of soreness of the throat; Little bit a soreness in throat, scratching of little bit but not too sore; or just allergies; Heart rate low/60 beats per minute; Ache in right side of my ribs; This is a spontaneous report from a contactable consumer (patient). A 53-years-old male patient received BNT162B2 (lot number: EJ1685) via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included fluticasone propionate. The patient was given vaccine shot (later clarified as Covid 19 vaccine) yesterday and just got a side effects of little sinus pressure, may be a little bit of soreness of the throat. About treatment, the patient took some Advil and he took some sinus pills, congestion pills a little bit earlier. It was clarified as nasal Decongestant, nasal congestion, 30mg, take 2 in 24 hours but he had taken two of them earlier along with 3 Advil pills. He deals with sinuses too but this one is like came on pretty much kind of overnight. He was wondering if doing the shot or something, he was not sure what's the matter or just allergies. It was just the sinus pressure yet. He didn't have the fever, not fever. Little bit a soreness in throat, scratching of little bit but not too sore. His heart rate is 60 per minute so it is low, 60 beats per minute, very low. He had just low heart rate though. About lab work the patient stated that went in for side pain, side ache in right side of his ribs. They did ear analysis, CBC. They all came back normal. He just wanted a report in and see he guessed just find it out if the symptoms go away or maybe he is having sinus infection going on or this sinus be going on so. Events outcome was unknown.
felt like A. Fib; Redness in site of vaccination; severe swelling to site; shortness in breath; weak; "my immune system is a mess"; missed a lot of work due to being sick; Still's disease/Still; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Right on 14Jun2021 14:38 (Batch/Lot Number: EW0177) as dose 2, single for COVID-19 immunization at a pharmacy. The patient's medical history was not reported. Concomitant medications were reported as none. The patient previously received the 1st dose of bnt162b2 (Lot number: Pfizer EW0177) on 24May2021 2:35 PM, at right upper arm at 51 years old for COVID-19 immunization and experienced Headache, Fever, Flu symptoms, and Congestion nasal. No relevant tests were done. On 14Jun2021 16:38, 2 hours after the 2nd dose, the patient went to the emergency room and the immunologist considers Still's disease/still and was given an unspecified treatment. On an unspecified date, the patient had felt something like A. fib, redness in site of vaccination and severe swelling to site, shortness in breath, and weak. The patient added that "my immune system is a mess. I have missed a lot of work due to being sick." The patient will be seeing an Immunologist. The outcome of the event Still's disease/still was not recovered, while for the rest of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Very irregular menstrual cycle for about 6 months or so; Cycle is every other week, sometimes shorter between times; Weight gain of almost 20 pounds during this time as well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 19Feb2021 (Lot number: EN9581) at the age of 33 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "covid" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Concomitant medication(s) included: CELEXA [CELECOXIB]; ALBUTEROL [SALBUTAMOL]. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Pfizer EN5318, Location of injection: Arm Left), administration date: 26Jan2021, when the patient was 33 years old, for Covid-19 immunization. The following information was reported: MENSTRUATION IRREGULAR (non-serious) with onset 15Mar2021, outcome "not recovered", described as "Very irregular menstrual cycle for about 6 months or so"; POLYMENORRHOEA (non-serious) with onset 15Mar2021, outcome "not recovered", described as "Cycle is every other week, sometimes shorter between times"; WEIGHT INCREASED (non-serious) with onset 15Mar2021, outcome "not recovered", described as "Weight gain of almost 20 pounds during this time as well". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of menstruation irregular, polymenorrhoea, weight increased.  Additional information :Patient did not receive other vaccine in four weeks of vaccination.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a pharmacist via a Center (case # US16-038842) refers to a 98 year old female patient. There was no information about the patient's concurrent conditions or medical history provided. Her historical medications included PROAIR and albuterol. On an unknown date in 2014, the patient was vaccinated with the first dose of ZOSTAVAX injection, once, lot # M003487 with expiration date: 21-APR-2017 (exact dose and route of administration were not provided). On 17-AUG-2016, the patient was vaccinated with the second dose of ZOSTAVAX injection (exact dose, route of administration, lot #, expiration date and anatomical location were not provided). Concomitant therapies included iron and unspecified blood pressure medications. It was reported, that the pharmacist was not aware that the patient had received one previously until the daughter called to say that her mother had one in 2014 already. Additional information has been requested.
Patient previously received 1 dose of Pfizer vaccine (3/31/2021-lot ER8732).
Information has been received from a nurse referring to unspecified number of patients of unknown age and gender. Since 31-DEC-2015 the patients were vaccinated with improperly stored PNEUMOVAX 23 SDV (lot# L019835 with expiration date of 23-MAR-2017, lot# L013428 with expiration date of 03-FEB-2017, dose, strength and route unknown). and PNEUMOVAX 23 PFS (lot# L0401478 with expiration date of 18-AUG-2017, dose, strength and route unknown). The vaccines were stored at 10 Celsius degree for 36 minutes. There was no previous temperature excursion. No adverse effects had been reported. This is one of the several reports received from the same reporter. Additional information has been requested.
102.8 degree F fever, left leg swelling/redness within one hour of immunization administration.
Confirmed Breakthrough   COVID-19 (Pfizer) 1 72 Years 7 Months 01/25/2021 Pharmacy  Pfizer EL3249   COVID-19 (Pfizer) 2 72 Years 8 Months 02/16/2021 Pharmacy  Pfizer EN6200   COVID-19 (Pfizer) 3 73 Years 3 Months 09/28/2021 Pharmacy  Pfizer FE3592   COVID-19 (Pfizer-BNT 30mcg) 4 73 Years 10 Months 03/31/2022 Pharmacy   Pfizer FK9894
69 expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (69 expired doses administered). On 11-Jan-2022, EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The  concomitant medications on use were not provided. No treatment information was provided.  On 06-Dec-2021, the vials were placed in refrigerator.   This case was linked to MOD-2022-449524 (Patient Link).
To ED for cough, dyspnes, fever;  +covid 12/24; Initial CXR: moderate infiltrates DX: Covid PNA, AKI Labs:  D-dimer 1.04; Cr. 4.37 (baseline 1.9- no HD PTA), CRP 12.53; Lactic Acid <1.02 TX: 60L/100% FiO2 HFNC in ED; Meds: No Remdesiver (symptoms started 9 days prior to arrival); Tocilizumab, eliquis, decadron, zinc, Vit C, melatonin intitated with admission 1/1/22 inflam markers: D-dimer 1.09; CRP: 2.84; Ferritin 3693; Procal 0.50; Rocephin started (empiric) AirVo 60/100 with intermittant NRB;  desats easily to 70's; gently hydration; prone positioning; refusing intubation 1/2 AirVo 60/100; spO2 91; prone positioning, 1/3 NSVT; AirVo 60/84; SpO2 96, prone; heparin added; 1/4 Airvo 60/100 SpO2 91; 1/5 AirVo 50/80; SpO2 90-91; 1/6 AirVo 60/80 SpO2 94; keeps taking oxygen off;  1/7 Airvo 55/75 Spox 86-91; 1/8 pt with self prone; spo2 to 60's; unresponsive; RRT intitated repositioned to supine; O2 to 100 BVM then to bipap after return to responsive Hgb drop; Upper GI bleed; protonix intitiated; no endoscopy due to instability; 1/11 Bipap continuously; GI stable, no further bleeding; 1/12 intubated; 1/13 kidneys failing; oliguric, K+ elevated; HD initiated; 1/14 Placed on Rotoprone bed; levo gtt started; DNR status; 1/15 Pt with bradycardia, hypotensive, hypoxic; pt expired
Bad stomach and chest pain. Extreme exhaustion and perspiration. They lasted 48 hours and ultimately
Initial report was received on 25 October 2011 from a health care professional. An "above 65" year-old patient (name, exact date of birth and gender not reported) had received a dose of FLUZONE HIGH-DOSE (lot number, route, site and date of administration not reported) and an unspecified amount of time later, experienced a seizure and was hospitalized with a high fever. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
Fever to 104 7 TMNX fever started day of vaccines - 103 first night / 104 7 next night - referred to ER by our office - leg swelling and pain (L thigh)
A few minutes after receiving the vaccine I began to feel light headed, dizzy and my heart rate was climbing. I wear an Apple Watch and notice my heart rate was steadily climbing. I asked the exit secretaries to be seen by a nurse and as they were getting a nurse my heart rate reached 169 and I was feeling faint and beginning to shake. When the nurse came she noticed how white my hands were and my breathing was becoming labored. The nurse called a code white and an ICU nurse and respiratory specialist arrived to assess me. I thought I would pass out and they had me lay on my back with legs up. They tested my blood sugar and were assessing my vitals. My breathing was fast but I was still able to breathe. My heart rate started to slow down but remained somewhat high. they helped me into a wheelchair and escorted me to the emergency department. I was assessed for cardiac concerns and labs were taken. After a couple of hours in the ED the dizziness started to subside but I had excessive thirst and dry mouth and slightly swollen tongue. I had feeling of butterflies in my stomach off an on. My heart rate stabilized and I was cleared to go home after four hours.
This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 4 days after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The reporter stated that he/she got shingles 4 days after booster, but it was better than getting covid. The follow-up would not be possible as no contact details were available.
she is not feeling well; She is itchy. She is itching on her arm, chest, back; She received Spikevax about 2 weeks ago and she has been experiencing allergies all over her body since then; This is the first time she receives Moderna vaccines, all her past doses were Pfizer and she didn´t experience anything like this; This is the first time she receives Moderna vaccines, all her past doses were Pfizer and she didn´t experience anything like this; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (she is not feeling well), PRURITUS (She is itchy. She is itching on her arm, chest, back), HYPERSENSITIVITY (She received Spikevax about 2 weeks ago and she has been experiencing allergies all over her body since then), INTERCHANGE OF VACCINE PRODUCTS (This is the first time she receives Moderna vaccines, all her past doses were Pfizer and she didn´t experience anything like this) and COVID-19 IMMUNISATION (This is the first time she receives Moderna vaccines, all her past doses were Pfizer and she didn´t experience anything like this) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Pfizer. Past adverse reactions to the above products included No adverse event with Pfizer.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (she is not feeling well), PRURITUS (She is itchy. She is itching on her arm, chest, back), HYPERSENSITIVITY (She received Spikevax about 2 weeks ago and she has been experiencing allergies all over her body since then), INTERCHANGE OF VACCINE PRODUCTS (This is the first time she receives Moderna vaccines, all her past doses were Pfizer and she didn´t experience anything like this) and COVID-19 IMMUNISATION (This is the first time she receives Moderna vaccines, all her past doses were Pfizer and she didn´t experience anything like this). At the time of the report, MALAISE (she is not feeling well) and PRURITUS (She is itchy. She is itching on her arm, chest, back) had not resolved and HYPERSENSITIVITY (She received Spikevax about 2 weeks ago and she has been experiencing allergies all over her body since then), INTERCHANGE OF VACCINE PRODUCTS (This is the first time she receives Moderna vaccines, all her past doses were Pfizer and she didn´t experience anything like this) and COVID-19 IMMUNISATION (This is the first time she receives Moderna vaccines, all her past doses were Pfizer and she didn´t experience anything like this) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication were reported.
Patient called county Public Health 1.5hrs after having received Day 7 in the Rabies PEP schedule. He stated that "I am having the most horrible headache of my life. I am feeling nauseous and my hands are shaking. My vision is blurry and I don't feel right. How long will this last?" Patient was advised that this is not the normal response to the vaccination and to seek medical evaluation at the closest ER. Patient presented to the ER at Medical Center for evaluation and treatment.
Pain LDM, rash face, neck, behind both ears inside rt elbow; red raised splotches; back of legs hurting; h/a, tongue feels swollen;
PATIENT IS COMPLAINING OF RANGE OF MOTION ISSUES, INFLAMMATION, AND PAIN IN LEFT ARM FROM VACCINE ADMINISTRATION
Injection was given SC rather than IM. I had baseball size swelling first day, second  day is 2 inch red and bruised circle that is hot to the touch
Unevaluable event; Gastric disorder; Vaccination adverse reaction; This spontaneous report received from a patient via a company representative concerned an adult female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number and expiry was not reported) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Non-company suspect drugs included: adalimumab (form of admin unknown, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported for moderate to severe adult Crohn's disease. No concomitant medications were reported. On an unspecified date, the patient experienced unevaluable event, gastric disorder, and vaccination adverse reaction.  On 09-NOV-2021, the patient was hospitalized for lot of complications (unevaluable event) and as per the patients physician that was not related to Crohn's.  On 14-NOV-2021, the patient was discharged. The action taken with covid-19 vaccine ad26.cov2.s, and adalimumab was not applicable. The patient was recovering from unevaluable event, and the outcome of gastric disorder and vaccination adverse reaction was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0-20220124979-Covid-19 vaccine ad26.cov2.s-Unevaluable event.This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
None before shot.  After shot extreme pain in right arm from neck down to fingers. Had Mri I had torn tendon for 4 years with no symptoms. First shit left arm no issues. Right arm extreme continual pain with no  improvement  to date.
fever to 100.6; leg swelled, fussy, vomiting evening of 25MAR93; On 27MAR93 AM awakened w/swollen lips & tongue lasted about 6 hrs; MD visit on 30MAR93;
slight dizziness; off balance; soreness at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the site of the injection), DIZZINESS (slight dizziness) and BALANCE DISORDER (off balance) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE PAIN (soreness at the site of the injection). On 15-Apr-2021, the patient experienced DIZZINESS (slight dizziness) and BALANCE DISORDER (off balance). At the time of the report, VACCINATION SITE PAIN (soreness at the site of the injection) had resolved and DIZZINESS (slight dizziness) and BALANCE DISORDER (off balance) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. concomitant medications were not provided.
This spontaneous report was received from a licensed practical nurse via a company representative refers to a female patient in her early 70's. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date and route not reported). On an unknown date the patient experienced local reaction to the injection site. The outcome of the event was unknown. Treatment information, lab diagnostic studies performed were unspecified by the reporter. Unspecified medical attention was sought for the event. Causality was not reported. Additional information is not expected.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A female patient received BNT162b2 (BNT162B2), on 29Jun2022 as dose number unknown (booster), single (Lot number: FM7553) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete, Unknown manufacturer), for COVID-19 immunization. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PAIN (non-serious), VACCINATION SITE INDURATION (non-serious) all with onset 29Jun2022, outcome "unknown" and all described as "it is like whole site red and a hard ball on the vaccinated area and so much hurting"; VACCINATION SITE MOVEMENT IMPAIRMENT (non-serious), outcome "unknown", described as "She cannot put her hand all the way up or down"; DRY SKIN (non-serious), SKIN EXFOLIATION (non-serious), outcome "unknown" and all described as "the patch looks like it is a dry and peeling off like skin is dry and peeling out"; PAIN (non-serious), outcome "unknown", described as "sometimes she did have pain". Additional information: The reporter reported for his/her mom. Reporter sent a picture to the provider and she said it was a reaction of the Pfizer.  No follow-up attempts are possible. No further information is expected.